Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Eric Golan, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by David Golan and Gerald Pier.
Connection Strength

0.488
  1. Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa. Am J Physiol Cell Physiol. 2009 Aug; 297(2):C263-77.
    View in: PubMed
    Score: 0.101
  2. Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2008 Mar; 49(3):1000-9.
    View in: PubMed
    Score: 0.094
  3. Host resistance to lung infection mediated by major vault protein in epithelial cells. Science. 2007 Jul 06; 317(5834):130-2.
    View in: PubMed
    Score: 0.090
  4. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect Immun. 2007 Apr; 75(4):1598-608.
    View in: PubMed
    Score: 0.087
  5. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc Natl Acad Sci U S A. 2002 May 14; 99(10):6907-12.
    View in: PubMed
    Score: 0.063
  6. Impact of heterogeneity within cultured cells on bacterial invasion: analysis of Pseudomonas aeruginosa and Salmonella enterica serovar typhi entry into MDCK cells by using a green fluorescent protein-labelled cystic fibrosis transmembrane conductance regulator receptor. Infect Immun. 2000 Feb; 68(2):861-70.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.